Trial
NCT05609825
A Study of LY3875383 in Healthy Participants and Participants With Hypertriglyceridemia
Phase ITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Eli Lilly and Company
Collaborators
—
Condition
Hypertriglyceridemia
Intervention
LY3875383
Why stopped
The study was terminated due to a change in risk/benefit ratio, which no longer favoured continued development.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-06-04